Yang Qiu

Yang Qiu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PLPing Luo
Ping Luo
SWShugui Wu
Shugui Wu
KJKAIBAO JI
KAIBAO JI
XYXia Yuan
Xia Yuan
HLHongmi Li
Hongmi Li
XZXiaoming Zhong
Xiaoming Zhong
Purpose: Cisplatin resistance is still a serious problem in the clinic. However, the underlying mechanism remains unknown. In our study, we investigated cisplatin resistance by using the cisplatin-resistant cell line HCT116R. Methods: The HCT116 cell line, a colon cancer cell line, was purchased. Cell viability was determined using CCK-8 Assay Kit. The gene expression levels of MIR4435-2HG, Nrf2, and HO-1, and caspase activity were determined using qRT-PCR and Caspase 3 Assay Kit, respectively. Results: In this study, we found that the levels of the lncRNA MIR4435-2HG were dramatically increased in the cisplatin-resistant cell line HCT116R. Knockdown of MIR4435-2HG in HCT116R cells significantly restored the sensitivity to cisplatin, inhibited cell proliferation and promoted cell apoptosis. Furthermore, Nrf2 and HO-1 mRNA levels, as critical molecules in the oxidative stress pathway, were inhibited by siRNAs targeting MIR4435-2HG, suggesting that MIR4435-2HG-mediated cisplatin resistance occurs through the Nrf2/HO-1 pathway. Conclusion: Our findings demonstrate that the lncRNA MIR4435-2HG is a main factor driving the cisplatin resistance of HCT116 cells.

20 March 2018 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
YQYang Qiu
Yang Qiu
RPRachel Perry
Rachel Perry
JCJoao Paulo Camporez
Joao Paulo Camporez
XZXian-Man Zhang
Xian-Man Zhang
MKMario Kahn
Mario Kahn
DVDaniel F. Vatner
Daniel F. Vatner
Exposure to the toxins methylene cyclopropyl acetic acid (MCPA) and methylene cyclopropyl glycine (MCPG) of unripe ackee and litchi fruit can lead to hypoglycemia and death; however, the molecular mechanisms by which MCPA and MCPG cause hypoglycemia have not been established in vivo. To determine the in vivo mechanisms of action of these toxins, we infused them into conscious rodents and assessed rates of hepatic gluconeogenesis and ketogenesis, hepatic acyl-CoA and hepatic acetyl-CoA content, and hepatocellular energy charge. MCPG suppressed rates of hepatic β-oxidation as reflected by reductions in hepatic ketogenesis, reducing both short- and medium-chain hepatic acyl-CoA concentrations. Hepatic acetyl-CoA content decreased, and hepatic glucose production was inhibited. MCPA also suppressed β-oxidation of short-chain acyl-CoAs, rapidly inhibiting hepatic ketogenesis and hepatic glucose production, depleting hepatic acetyl-CoA content and ATP content, while increasing other short-chain acyl-CoAs. Utilizing a recently developed positional isotopomer NMR tracer analysis method, we demonstrated that MCPA-induced reductions in hepatic acetyl-CoA content were associated with a marked reduction of hepatic pyruvate carboxylase (PC) flux. Taken together, these data reveal the in vivo mechanisms of action of MCPA and MCPG: the hypoglycemia associated with ingestion of these toxins can be ascribed mostly to MCPA- or MCPG-induced reductions in hepatic PC flux due to inhibition of β-oxidation of short-chain acyl-CoAs by MCPA or inhibition of both short- and medium-chain acyl-CoAs by MCPG with resultant reductions in hepatic acetyl-CoA content, with an additional contribution to hypoglycemia through reduced hepatic ATP stores by MCPA.

21 December 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
ZWZhen Wang
Zhen Wang
JLJunfeng Lu
Junfeng Lu
JZJingwei Zhou
Jingwei Zhou
WSWeiwei Sun
Weiwei Sun
YQYang Qiu
Yang Qiu
LPLiang Peng
Liang Peng
Obesity and related metabolic disorders are associated with intestinal microbiota dysbiosis, disrupted intestinal barrier and chronic inflammation. Shen-Yan-Fang-Shuai formula (SYFSF) is a traditional Chinese herbal formula composed of Astragali Radix, Radix Angelicae Sinensis, Rheum Officinale Baill, and four other herbs. In this study, we identified that SYFSF treatment prevented weight gain, low-grade inflammation and insulin resistance in high-fat diet (HFD)-fed mice. SYFSF also substantially improved gut barrier function, reduced metabolic endotoxemia, as well as systemic inflammation. Sequencing of 16S rRNA genes obtained from fecal samples demonstrated that SYFSF attenuated HFD-induced gut dysbiosis, seen an decreased Firmicutes to Bacteroidetes ratios. Microbial richness and diversity were also higher in the SYFSF-treated HFD group. Furthermore, similar therapeutic effects and changes in gut microbiota profile caused by SYFSF could be replicated by fecal microbiota transfer (FMT). Taken together, our study highlights the efficacy of SYFSF in preventing obesity and related metabolic disorders. Its therapeutic effect is associated with the modulation of gut microbiota, as a prebiotic.

27 July 2021 in Genes & Genomics
Verified
Journal Article
Closed access
PDF file
YQYang Qiu
Yang Qiu
YYYonggang Yuan
Yonggang Yuan
PLPing Luo
Ping Luo

31 October 2018 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
BHBingqing Hu
Bingqing Hu
HHHaidi Hu
Haidi Hu
MYMingzhu Yin
Mingzhu Yin
ZSZhengrong Sun
Zhengrong Sun
XCXiaoya Chen
Xiaoya Chen
YQYang Qiu
Yang Qiu

11 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
RCRenzhi Chen
Renzhi Chen
CLChong Liu
Chong Liu
HPHaizhou Pan
Haizhou Pan
XLXinyang Li
Xinyang Li
HWHengzhen Wang
Hengzhen Wang
HHHaidi Hu
Haidi Hu
Background Free testosterone (FT) demonstrates significant associations with cardiovascular diseases (CVDs). However, the precise relationship and underlying mediators linking FT and abdominal aortic calcification (AAC) remain incompletely understood. This study combined data from NHANES cross-sectional studies with Mendelian randomization (MR) and mediation MR analyses to assess the causal relationship between FT and AAC, and further identified lipid metabolites as potential mediators. Methods Cross-sectional analysis utilized National Health and Nutrition Examination Survey (NHANES) data collected during 2013–2014, encompassing 2,654 individuals. Associations between severe AAC (SAAC) and FT were investigated using weighted multivariable regression, subgroup analyses, and restricted cubic spline (RCS) regression models. Moreover, to verify causal inference, bidirectional two-sample MR analyses were implemented utilizing European ancestry genome-wide association study (GWAS) data. Subsequently, mediation MR analyses were conducted to quantify the contribution of lipid metabolites to the observed associations. Results A significant inverse association was observed between FT and SAAC; compared to participants in the lowest FT quartile, those in the highest quartile had a 67.9% lower risk (odds ratio [OR] = 0.321, 95% confidence interval [CI]: 0.194– 0.529, P value [P] < 0.001). The nonlinear inverse relationship between FT and SAAC was further confirmed by RCS regression (P for nonlinearity = 0.010). MR and mediation analyses corroborated the causal impact of FT on AAC (inverse variance-weighted [IVW] OR = 0.969, 95% CI: 0.941–0.997, P = 0.033). Four lipid-associated metabolites mediated approximately 36.13% of this causal link, namely mean low-density lipoprotein (LDL) particle diameter, triglycerides to total lipid ratio in large high-density lipoprotein (HDL) particles, total cholesterol to total lipid ratio in chylomicrons and extremely large very low-density lipoprotein (VLDL), and cholesteryl ester to total lipid ratio in chylomicrons and extremely large VLDL. Conclusions Elevated FT independently associates with a reduced AAC risk and exerts causal effects mediated by lipid metabolic pathways. These findings highlight FT regulation as a potential target for AAC prevention and provide new insights for therapeutic strategies against vascular calcification (VC).